Phase I study of Abt-530 in healthy adults.

Trial Profile

Phase I study of Abt-530 in healthy adults.

Phase of Trial: Phase I

Latest Information Update: 01 Jan 2017

At a glance

  • Drugs Pibrentasvir (Primary) ; Ritonavir
  • Indications Hepatitis C
  • Focus Adverse reactions; First in man; Pharmacokinetics
  • Sponsors AbbVie
  • Most Recent Events

    • 21 Apr 2016 New trial record
    • 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top